The global economy becomes more closely knit each year. The economic expansion of quickly developing countries requires resources to fuel the fire, and lots of them. The most efficient way to transport mass quantities of raw materials is through dry bulk shipping using large vessels. Assuming that teleportation devices won't be introduced anytime soon, the bulk shipping industry is here for the long haul.
Shipping services are all fairly standard: The materials are loaded, shipped, and unloaded. Therefore it is difficult for a company to differentiate itself based on quality of service, so other avenues such as rate competitiveness and cost efficiency become big factors in a company's success. A great example of a company doing just this is DryShips (NASDAQ: DRYS ) .
The good
Through what has been a difficult period for shipping stocks, DryShips has done a great job growing revenues. Over the past two years, revenues have been growing year over year at relatively high rates and have hit $319.7 million, a 29% increase over the same quarter last year. The fact that DryShips can maintain revenues during an imbalanced period of supply and demand gives the company a promising outlook.
Top 5 Transportation Stocks To Buy Right Now: Ramelius Resources Ltd (RMS)
Ramelius Resources Limited is engaged in exploration, mine development, mine operations, the sale of gold and milling services. The Company operates in three segments: Exploration, Burbanks, and Mt Magnet. The Company�� exploration project includes Mt Magnet Project, Mt Windsor Joint Venture, Nevada Project, Vivien Project and Coogee Project. The Mt Magnet gold project is located 600 kilometer north of Perth in the Murchison Goldfield of the Western Australian Yilgarn Craton. The Western Queen South project is located 90 kilometer north-west of Mt Magnet. The Burbanks Treatment Plant is located 8 kilometer south of the town of Coolgardie and 65 kilometer from the Wattle Dam Gold Mine. The Vivien gold deposit is located near the Agnew Gold Mine, west of the town of Leinster in Western Australia. The Coogee gold deposit is located on mining lease 26/477, 23 kilometer east northeast of Kambalda. In October 2013, the Company acquired Vivien gold project. Advisors' Opinion:- [By Namitha Jagadeesh]
Hermes (RMS) added 2.1 percent to 253.70 euros. The French maker of Kelly bags reported first-half operating profit rose 14 percent to 584.1 million euros ($773.6 million), exceeding the 569 million-euro average estimate of analysts in a Bloomberg survey. It also confirmed its July forecast that sales in 2013, excluding currency swings, will increase more than 10 percent.
Top 5 Promising Companies To Own In Right Now: Hudson Global Inc (HSON)
Hudson Global, Inc. (Hudson) incorporated on January 1, 2003, provides specialized professional-level recruitment and related talent solutions worldwide. The Company's Core service offerings include Permanent Recruitment, Contract Consulting, Legal eDiscovery, Recruitment Process Outsourcing (RPO) and Talent Management solutions. As of December 31, 2012, the Company operated in 20 countries with three geographic business segments: Hudson Americas, Hudson Asia Pacific, and Hudson Europe. The Company's core service offerings include Permanent Recruitment, Contract Consulting, Legal eDiscovery,RPO and Talent Management Solutions.
The Company's Permanent Recruitment services leverage the firm's more than 1,200 consultants, supported by the Company's psychologists and other scientific specialists in the development and delivery of its methods to identify, select and engage the best-fit talent for critical client roles. In Contract Consulting, Hudson provides a range of project management, interim management and professional contract staffing services. Hudson's Legal eDiscovery services consists of eDiscovery solutions, managed document review including logistical deployment, project management, process design and productivity management, and contract attorney staffing. Hudson's RPO delivers outsourced recruitment solutions tailored to the individual needs of mid- to large-cap multinational companies. Hudson RPO services include complete recruitment outsourcing, project-based outsourcing, contingent workforce solutions and recruitment consulting. Hudson's Talent Management Solutions capability encompasses services such as talent assessment, interview training, executive coaching, employee development and outplacement.
The Company's clients include small to large-sized corporations and government agencies. As of December 31, 2012 , there were approximately 460 Hudson Americas clients, 1,200 Hudson Asia Pacific clients and 2,700 Hudson Europe clients.
Advisors' Opinion:- [By John Udovich]
The government's closely watched jobs report today is expected to show that nonfarm payrolls increased by 218,000 positions and may have finally returned employment to its pre-recession level, but executive search or staffing stocks like Hudson Global Inc (NASDAQ: HSON), Robert Half International Inc (NYSE: RHI) and up and coming Staffing 360 Solutions Inc (OTCBB: STAF) have already made investors winners since the official end of the recession:
- [By John Udovich] Staffing 360 Solutions Inc. Having a consolidation strategy that is well suited for the highly fragmented temporary staffing industry, small cap Staffing 360 Solutions is an interesting staffing stock because it intends to become a major international publicly-held staffing organization�through a�targeted accretive acquisition strategy.�The company�has already developed a significant pipeline of acquisition targets in the IT, financial, accounting, healthcare and banking industries while its executive chairman Brendan Flood spent seven years at Hudson Global Inc (NASDAQ: HSON) in various roles in Europe and the United States. His stint at�Hudson Global�culminated with him leading the company's IPO on the Nasdaq in 2003. During 2004 and 2005, Flood was also the CFO/COO for Hudson North America when he returned the business to profitability after several loss-making years (Note:�Before the�IPO, Hudson was part of what is now Monster Worldwide, Inc (NYSE: MWW)). In addition, CEO Matt Briand has 17 years of staffing industry experience from various recruitment, sales, management and executive roles. Back in June,�Staffing 360 Solutions announced revised revenue guidance for the company's fiscal quarter ended May 31, 2014, with revenue now expected to be in excess of $26.8 million, as opposed to the verses a previously forecast amount of $24.1 million for an increase of $2.7 million or 11% over the forecast. The update also noted that Staffing 360 Solutions has�successfully completed five acquisitions over the past year, including operations in the United States and Europe.�Moreover, Staffing 360 Solutions previously reported revenues of approximately $557,000 for the quarter ended May 31, 2013 versus $26.8 million for the quarter ended May 31, 2014 for a year-over-year increase of $26.2 million or 4,711%. On Thursday, Staffing 360 Solutions fell 1.02% to $1.95 (STAF has a 52 week trading range of $0.55 to $2.20 a share) for a market cap of $59.75 mill
Top 5 Promising Companies To Own In Right Now: Yamana Gold Inc.(AUY)
Yamana Gold Inc. engages in gold and other precious metals mining, and related activities, including exploration, extraction, processing, and reclamation. It also explores for copper, molybdenum, zinc, and silver metals. The company's portfolio includes 7 operating gold mines namely Chapada; El Pen Advisors' Opinion:
- [By Ben Levisohn]
Earnings from Yamana Gold (AUY) and Barrick Gold (ABX), as well as the death of the merger between Barrick and Newmont Mining (NEM), are weighing on gold miners this morning.
Associated PressBarrick Gold reported a profit of 20 cents a share, beating forecasts for 19 cents a share, on sales of $2.63 billion. Analysts had expected $2.6 billion. Barrick also lowered its copper guidance. No mention was made of a merger with Newmont Mining in Barrick’s press release.
Yamana Gold, meanwhile, reported a profit of 2 cents a share, missing forecasts for 4 cents. It said it will focus on its Canadian and Argentine operations.
Morgan Stanley’s Brad Humphrey and team assess Yamana’s miss:
[Yamana's] 1Q14 results missed consensus but were in line with our estimates. Gold and copper output came in below our forecasts, offset by lower than expected expenses. Due to seasonality, [Yamana] typically reports a weaker 1H. Given April results provided, output is trending up in Q2.�[Yamana] Shares could be weak initially on back of consensus miss but going fwd, output is expected to trend up QoQ and if successful acquiring 50% of Osisko, political risk profile improves, with the addition of this material, long life, low cost asset.
Cowen’s Adam Graf and Misha Levental
[Barrick] 1Q14 adjusted earnings of $0.20/share, slightly ahead of consensus, down from $0.92/share y/y. The decrease primarily reflects the impact of lower metal prices and lower gold sales volumes. Additionally, lower earnings reflect the impact of asset sales that occurred since the second half of 2013, including the sale of the Kanowna and Plutonic mines in Australia and its 33% stake in the Marigold mine in Nevada in 2014.
Full-year guidance remains on track for gold at 6.0-6.5MM oz Au at AISC of $920- $980/oz. Copper production has lowered, however, to 410-440MM lbs Cu (from 470-500MM), at original cost guidance of $1.90-$2.10/lb Cu. C
- [By Itinerant]
Goldcorp, Newmont (NEM) or Agnico-Eagle use similar definitions. The important element here is the so-called 'sustaining capital expenditure', which is the capital required to sustain existing production levels. The table below is taken from the Agnico-Eagle presentation referenced above and provides a comparison of company-wide AISC for some of the major gold miners, including Goldcorp, Barrick Gold, Newmont Mining, Yamana Gold (AUY), Randgold (GOLD), Kinross (KGC), Agnico-Eagle Mines, Eldorado Gold (EGO), Goldfields and Centerra (CAGDF.PK). The difference between cash costs and AISC is significant. It is also important to note that these AISC are still noticeably below the present spot price for gold.
- [By Dan Caplinger]
Yamana Gold (NYSE: AUY ) will release its quarterly report on Wednesday, and investors already understand that the plunge in gold prices that came in April will have a huge negative impact on the company's financial success. Yet even as other less healthy gold miners expect sizable losses, Yamana earnings should remain positive and give the company a good chance to endure the adverse pricing environment with minimal damage.
Top 5 Promising Companies To Own In Right Now: Cytokinetics Incorporated(CYTK)
Cytokinetics, Incorporated, a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions. It primarily offers omecamtiv mecarbil, a cardiac muscle myosin activator, which is in Phase I/IIa clinical trials for the treatment of heart failure; CK-2017357, which is a Phase IIa clinical trials for the treatment of amyotrophic lateral sclerosis; and CK-2066260, a fast skeletal muscle sarcomere activator for the treatment of diseases and conditions associated with muscle weakness or wasting. The company?s cancer treatment products under development stage comprise ispinesib, SB-743921, and GSK-923295. It has a strategic alliance with Amgen Inc. to discover, develop, and commercialize novel small molecule therapeutics that activate cardiac muscle contractility for applications in the treatment of heart failure. The company was founded in 1997 and is headquartered in South San Francisco, California.
Advisors' Opinion:- [By Rick Munarriz]
Tuesday
Cytokinetics (NASDAQ: CYTK ) checks in on Tuesday. The biotech company's lead candidate is a cardiac muscle contractility program that Cytokinetics is trying to get approved for the potential treatment of heart failure. Investors see red ink here, but analysts do see the quarterly deficit narrowing this time around. - [By Sean Williams]
What: Shares of Cytokinetics (NASDAQ: CYTK ) , a clinical-stage biopharmaceutical company focused on developing therapies for serious diseases, tanked as much as 38% after reporting mid-stage top-line data from acute heart failure drug, omecamtiv mecarbil.
No comments:
Post a Comment